Wall Street RegretsThe regret calculator.

What if you'd held LCTX?

A $1,000 investment in Lineage Cell Therapeutics, Inc. (LCTX) at the month-end close of 1992-03 would be worth $426 at the close of 2026-08 — -57.4% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $19,094.

$1,000 since 1992$426Total return-57.4%Multiple0.43×CAGR-2.4%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$426Gain+$-574 (-57.4%)Multiple0.4×CAGR-2.4%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2000$1622001$1922002$3132003$9282004$9872005$9022006$4,4002007$5,0462008$3,3232009$7702010$3222011$1642012$2352013$4342014$3792015$3652016$3322017$3482018$5852019$1,2092020$1,2362021$6252022$4492023$9402024$1,0092025$2,2002026$659

    Every year, $1,000 from 1992

    YearValue of $1,000Year return
    1992$1,000
    1993$808-19.2%
    1994$205-74.6%
    1995$320+56.1%
    1996$2,872+796.5%
    1997$5,846+103.6%
    1998$5,346-8.6%
    1999$2,731-48.9%
    2000$2,308-15.5%
    2001$1,415-38.7%
    2002$477-66.3%
    2003$448-6.0%
    2004$491+9.4%
    2005$101-79.5%
    2006$87.73-12.8%
    2007$133+51.8%
    2008$575+331.7%
    2009$1,374+138.9%
    2010$2,705+96.9%
    2011$1,887-30.3%
    2012$1,020-46.0%
    2013$1,169+14.7%
    2014$1,211+3.6%
    2015$1,332+9.9%
    2016$1,271-4.6%
    2017$757-40.4%
    2018$366-51.6%
    2019$358-2.2%
    2020$708+97.8%
    2021$986+39.2%
    2022$471-52.2%
    2023$439-6.8%
    2024$201-54.1%
    2025$672+234.0%
    2026$443-34.1%

    Best and worst month-end to buy

    The best single month-end close to have bought LCTX was 2006-09 ($0.17): $1,000 then is $6,509 today. The worst was 1997-10 ($18.83): $1,000 then is $58.42.

    FAQ

    What would $1,000 in LCTX be worth today?

    A $1,000 investment in Lineage Cell Therapeutics, Inc. (LCTX) at the start of 1992 would be worth about $426 today, a total return of -57.4%. Dividends are reinvested in these figures.

    What were the best and worst years for LCTX?

    Lineage Cell Therapeutics, Inc. (LCTX)'s strongest calendar year since 1992 was 1996, a +796.5% return — $1,000 held through that year became about $8,965 by year-end. Its weakest year was 2005, at -79.5%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in LCTX have grown?

    Investing $100 at the end of every month since 1992-03 would have grown to about $38,828 on $41,400 invested.

    Did LCTX beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $19,094. LCTX trailed the S&P 500 by +97.8% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    Lineage Cell Therapeutics, Inc. (LCTX) historical total-return data from 1992-03 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.